Phadke, M. S., Sini, P., & Smalley, K. S. M. (2015). The novel ATP-competitive MEK/Aurora kinase inhibitor BI-847325 overcomes acquired BRAF inhibitor resistance through suppression of Mcl-1 and MEK expression. Mol Cancer Ther.
シカゴスタイル引用形Phadke, Manali S., Patrizia Sini, , Keiran S. M. Smalley. "The Novel ATP-competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance Through Suppression of Mcl-1 and MEK Expression." Mol Cancer Ther 2015.
MLA引用形式Phadke, Manali S., Patrizia Sini, , Keiran S. M. Smalley. "The Novel ATP-competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance Through Suppression of Mcl-1 and MEK Expression." Mol Cancer Ther 2015.
警告: この引用は必ずしも正確ではありません.